Other and unspecified psoriasis

L12_PSORI_NAS

psoriasis: An autoimmune condition characterized by red, well-delineated plaques with silvery scales that are usually on the extensor surfaces and scalp. They can occasionally present with these manifestations: pustules; erythema and scaling in intertriginous areas, and erythroderma, that are often distributed on extensor surfaces and scalp.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 L40.8, L40.9
  • Hospital discharge: ICD-9 6968X
  • Hospital discharge: ICD-8 69619
  • Cause of death: ICD-10 L40.8, L40.9
  • Cause of death: ICD-9 6968X
  • Cause of death: ICD-8 69619

2 out of 7 registries used, show all original rules.

2533

4. Check minimum number of events

None

2533

5. Include endpoints

None

2533

6. Filter based on genotype QC (FinnGen only)

2533

Control definitions (FinnGen only)

Control exclude
L12_PAPULOSQUAMOUS

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 17507 7898 9423
Only index persons 14685 6954 7731
Unadjusted period prevalence (%)
Whole population 0.25 0.23 0.26
Only index persons 0.28 0.26 0.30
Median age at first event (years)
Whole population 50.61 51.59 49.78
Only index persons 49.46 50.13 48.86

-FinnGen-

Key figures

All Female Male
Number of individuals 2533 1252 1281
Unadjusted period prevalence (%) 0.50 0.43 0.56
Median age at first event (years) 51.33 49.95 52.66

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2249
Matched controls
22492
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L40.9
ICD-10 Finland
Psoriasis, unspecified
921.9
323.0
1194
28
69619
ICD-8 Finland
Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)
+∞
323.0
530
*
D05AX02
ATC
calcipotriol; topical
115.7
323.0
1069
175
E0000UV
ATC
NA
7.5
323.0
1622
5757
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
13.6
323.0
809
890
L40
ICD-10 Finland
Psoriasis
84.1
323.0
373
53
D05AX52
ATC
calcipotriol, combinations; topical
92.4
323.0
1205
277
E000001
ATC
NA
7.5
323.0
1094
2509
L40.5
ICD-10 Finland
Arthropathic psoriasis
1156.0
323.0
461
5
D07AC01
ATC
betamethasone; topical
9.1
323.0
1596
4778
D05AX03
ATC
calcitriol; topical
118.5
323.0
400
41
L40.0
ICD-10 Finland
Psoriasis vulgaris
462.1
323.0
1232
58
D07AD01
ATC
clobetasol; topical
11.3
323.0
1055
1632
D05BB02
ATC
acitretin; oral
146.5
323.0
586
54
D07XC01
ATC
betamethasone, combinations; topical
24.1
323.0
1301
1213
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
1142.8
323.0
527
6
L40.8
ICD-10 Finland
Other psoriasis
1926.0
323.0
765
6
D07AC13
ATC
mometasone; topical
4.9
257.4
1176
4078
319
Kela drug reimbursment
Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)
+∞
230.2
217
*
D07AB02
ATC
hydrocortisone butyrate; topical
4.5
223.2
1091
3884
M07.3
ICD-10 Finland
Other psoriatic arthropathies
223.7
217.7
222
11
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
6.2
191.6
589
1221
E000002
ATC
NA
6.0
185.1
583
1240
S91
ICPC
Psoriasis
150.6
183.6
193
14
E000003
ATC
NA
11.0
171.7
346
366
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
11.6
169.4
332
332
134
Kela drug reimbursment
General erythroderma
349.8
164.3
164
5
6961A
ICD-9 Finland
Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]
+∞
160.3
152
*
D07AB08
ATC
desonide; topical
5.4
151.4
512
1157
D05AA
ATC
Tars
83.9
139.4
156
20
L04AB04
ATC
adalimumab; parenteral
19.7
132.1
204
113
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
31.5
116.5
156
53
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
3.1
111.2
783
3277
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
6.1
111.1
329
616
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.7
109.7
417
1038
A07EC01
ATC
sulfasalazine; oral, rectal
5.1
109.5
379
853
D02AE01
ATC
carbamide; topical
5.8
109.0
338
669
L40.4
ICD-10 Finland
Guttate psoriasis
272.8
102.7
104
*
TQW80
NOMESCO Finland
Local dermatologic skincare
11.2
100.0
196
190
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
32.7
95.9
127
41
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
5.0
89.3
313
705
M07.0*L40.5
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
892.3
88.3
86
*
L04AC05
ATC
ustekinumab; parenteral
100.3
87.7
96
10
L04AC10
ATC
secukinumab; parenteral
121.2
86.6
93
8
E000006
ATC
NA
4.9
85.6
302
684
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
10.1
84.1
174
186
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
9.5
84.0
179
202
377
Kela drug reimbursment
Apremilast and dimethyl fumarate (psoriasis)
+∞
79.6
76
*
6960A
ICD-9 Finland
Psoriasis and similar disorders, Psoriatic arthropathy
+∞
78.6
75
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.0
77.9
547
2194
H02AB06
ATC
prednisolone; systemic
2.3
72.6
1180
7400
L04AB01
ATC
etanercept; parenteral
15.1
70.2
119
83
L04AC13
ATC
ixekizumab; parenteral
+∞
65.9
63
*
L04AA32
ATC
apremilast; oral
+∞
62.8
60
*
69600
ICD-8 Finland
Psoriasis and similar disorders, Psoriatic arthropathy
+∞
59.6
57
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
57.2
1078
6938
E000007
ATC
NA
4.6
57.2
211
493
D07AA02
ATC
hydrocortisone; topical
2.8
55.6
399
1587
D07XB01
ATC
flumetasone, combinations; topical
22.1
53.8
79
37
D07BC01
ATC
betamethasone and antiseptics; topical
2.9
53.4
372
1445
L04AD01
ATC
ciclosporin; systemic
8.6
52.7
118
144
L04AA13
ATC
leflunomide; oral
6.9
52.4
136
208
L04AA01
ATC
[U] ciclosporin; systemic
9.5
52.2
110
121
L04AC16
ATC
guselkumab; systemic
+∞
51.2
49
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.2
48.7
277
935
D05AX05
ATC
tazarotene; topical
125.2
45.9
49
*
M07.0
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
456.6
45.4
45
*
D02AX
ATC
Other emollients and protectives
5.7
45.3
136
252
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
47.4
42.1
51
11
D05AC01
ATC
dithranol; topical
146.0
40.9
43
*
A46
ICD-10 Finland
Erysipelas
2.4
38.4
371
1715
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.0
37.9
239
860
D07CC01
ATC
betamethasone and antibiotics; topical
2.4
36.5
346
1582
M25.5
ICD-10 Finland
Pain in joint
1.9
36.4
642
3844
L40.1
ICD-10 Finland
Generalized pustular psoriasis
+∞
33.4
32
*
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.3
33.3
331
1544
J01FF01
ATC
clindamycin; systemic
1.9
33.0
632
3871
M13.9
ICD-10 Finland
Arthritis, unspecified
2.9
32.7
208
753
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
5.9
32.5
93
163
N02AX02
ATC
tramadol; systemic, rectal
1.7
31.8
952
6722
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
31.5
711
4592
J01DB01
ATC
cefalexin; oral
1.8
30.9
1796
15364
E000004
ATC
NA
6.2
30.7
84
139
L88
ICPC
Rheumatoid/seropositive arthritis
3.8
30.0
133
367
H02AB07
ATC
prednisone; oral
2.2
29.9
349
1749
L04AA11
ATC
[U] etanercept; parenteral
21.9
29.6
43
20
L43.8
ICD-10 Finland
Other lichen planus
37.6
29.3
37
10
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.6
29.2
227
927
M07.2*L40.5
ICD-10 Finland
Psoriatic spondylitis
+∞
28.2
27
*
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
5.1
28.1
91
185
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
27.6
651
4225
D05AX
ATC
Other antipsoriatics for topical use
274.2
26.8
27
*
D09AB01
ATC
zinc bandage without supplements; topical
6.0
26.5
74
126
C03CA01
ATC
furosemide; systemic
1.8
26.2
607
3907
NH3EA
NOMESCO Finland
Feet X-ray examination with load
5.3
25.7
80
156
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.3
24.9
237
1075
J01DA01
ATC
[U] cefalexin; systemic
1.6
24.7
1340
10810
L30.3
ICD-10 Finland
Infective dermatitis
3.7
24.3
109
304
A02BC02
ATC
pantoprazole; systemic
1.6
23.9
1390
11362
N05BB01
ATC
hydroxyzine; systemic
2.7
23.6
164
626
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
23.6
1213
9603
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
23.2
515
3250
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
22.4
509
3233
R06AE07
ATC
cetirizine; oral
1.6
21.2
870
6460
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
21.1
842
6207
D07AC14
ATC
methylprednisolone aceponate; topical
3.0
21.1
128
449
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
21.0
586
3938
L28
ICPC
Limited function/disability (L)
1.9
20.2
329
1863
UJF32
NOMESCO Finland
Coloscopy
1.7
20.2
556
3717
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
20.1
300
1647
SPAT1263
SPAT
Sampling
1.5
20.1
868
6504
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
20.0
219
1056
XQ848
NOMESCO Finland
Dermatological photography
4.0
20.0
82
213
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.3
19.7
102
320
WQ031
NOMESCO Finland
NA
201.7
19.6
20
*
D07AB01
ATC
clobetasone; topical
3.6
19.4
89
254
S97
ICPC
Chronic ulcer skin
2.7
19.4
134
508
XQ802
NOMESCO Finland
Epicutan test
3.2
19.4
105
341
S29
ICPC
Skin symptom/complaint other
1.8
19.1
356
2113
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
6.3
18.8
50
81
299
Kela drug reimbursment
NA
+∞
18.8
18
*
L26
ICD-10 Finland
Exfoliative dermatitis
18.9
18.6
28
15
L04AX01
ATC
azathioprine; systemic
2.9
18.5
117
422
N02BE01
ATC
paracetamol; systemic, rectal
1.6
18.3
1830
16402
M04AA01
ATC
allopurinol; systemic
1.9
18.3
289
1617
TNG10
NOMESCO Finland
Puncture of knee
5.8
18.1
51
89
WX110
NOMESCO Finland
Local anesthesy
1.5
18.1
1406
11871
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
18.0
566
3898
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.0
17.8
231
1198
M07.1*L40.5
ICD-10 Finland
Arthritis mutilans
+∞
17.7
17
*
WQ021
NOMESCO Finland
NA
37.0
17.6
22
6
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.3
17.6
161
715
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
17.5
215
1091
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.1
17.4
205
1020
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.9
17.4
278
1560
SPAT1262
SPAT
Handing over of treatment supplies
1.7
17.3
396
2496
S02CA02
ATC
flumetasone and antiinfectives; otic
2.5
17.2
139
578
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.6
16.9
125
496
E66.8
ICD-10 Finland
Other obesity
2.6
16.8
124
492
L40.2
ICD-10 Finland
Acrodermatitis continua
+∞
16.7
16
*
E66.00
ICD-10 Finland
Metabolic syndrome
2.5
16.6
132
546
R60.0
ICD-10 Finland
Localized oedema
2.0
16.5
230
1226
S18
ICPC
Laceration/cut
1.5
16.4
845
6494
WZA10
NOMESCO Finland
Long statement of health and health related matters
5.2
16.4
50
97
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.8
16.4
287
1661
A10BA02
ATC
metformin; oral
1.6
16.3
570
4017
S76
ICPC
Skin infection other
2.6
16.3
124
500
K50.1
ICD-10 Finland
Crohn disease of large intestine
5.6
16.2
47
86
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.6
16.0
122
492
RJ411
NOMESCO Finland
NA
9.0
15.9
33
37
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
15.7
339
2096
R03AC02
ATC
salbutamol; inhalant
1.4
15.3
1039
8408
J02AC01
ATC
fluconazole; systemic
1.5
15.3
755
5731
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
15.3
239
1331
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
15.2
502
3478
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
15.2
433
2891
L04AB06
ATC
golimumab; parenteral
7.4
15.0
35
48
M45
ICD-10 Finland
Ankylosing spondylitis
3.7
14.9
64
175
R06.0
ICD-10 Finland
Dyspnoea
1.6
14.8
493
3426
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.2
14.7
152
715
L43.9
ICD-10 Finland
Lichen planus, unspecified
9.8
14.7
29
30
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.9
14.7
234
1310
D07AC03
ATC
desoximetasone; topical
4.2
14.7
55
133
H02AB04
ATC
methylprednisolone; systemic
1.7
14.6
305
1864
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
14.5
202
1077
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
14.5
286
1720
L04AB05
ATC
certolizumab pegol; parenteral
17.1
14.3
22
13
D01AC02
ATC
miconazole; topical
2.0
14.2
184
955
G47.3
ICD-10 Finland
Sleep apnoea
1.6
14.2
448
3069
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
14.0
303
1875
E66.01
ICD-10 Finland
Obesity due to excess calories
2.1
14.0
163
810
L17
ICPC
Foot/toe symptom/complaint
1.5
13.9
489
3431
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.5
13.9
108
441
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.2
13.8
141
661
N05CF01
ATC
zopiclone; oral
1.5
13.8
640
4774
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.0
13.6
79
272
L04AC18
ATC
risankizumab; parenteral
+∞
13.6
13
*
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.5
13.5
109
454
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
3.6
13.4
60
170
M54.5
ICD-10 Finland
Low back pain
1.5
13.4
632
4722
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
13.4
322
2049
J01MA02
ATC
ciprofloxacin; systemic
1.4
13.3
779
6076
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
13.3
221
1258
A06AD11
ATC
lactulose; oral
1.7
13.2
275
1680
A10BJ02
ATC
liraglutide; parenteral
3.4
13.2
64
194
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
13.1
567
4161
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.4
13.0
800
6291
XQ800
NOMESCO Finland
Prick test
2.1
12.9
144
699
D07XB02
ATC
triamcinolone, combinations; topical
4.3
12.9
47
111
R4180
NOMESCO Finland
Podiatric therapy
5.3
12.8
38
72
SPAT1254
SPAT
Administration of medicine
1.7
12.8
281
1742
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.2
12.8
137
657
A02BC01
ATC
omeprazole; systemic
1.5
12.8
541
3947
160
Kela drug reimbursment
exenatide
3.6
12.7
57
162
TQW99
NOMESCO Finland
Other minor procedure on skin
2.4
12.7
108
464
R03BB04
ATC
tiotropium bromide; inhalant
1.8
12.7
212
1205
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
12.6
334
2180
K50.8
ICD-10 Finland
Other Crohn disease
4.2
12.6
47
114
L43.0
ICD-10 Finland
Hypertrophic lichen planus
70.3
12.6
14
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
12.6
227
1322
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.6
12.6
56
159
RJ421
NOMESCO Finland
NA
8.3
12.5
27
33
A10AE04
ATC
insulin glargine; parenteral
1.9
12.5
196
1089
WQ032
NOMESCO Finland
NA
+∞
12.5
12
*
L04AA21
ATC
efalizumab; parenteral
+∞
12.5
12
*
A10BH01
ATC
sitagliptin; oral
1.9
12.5
196
1092
N05CD07
ATC
temazepam; oral
1.7
12.4
256
1557
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.2
12.3
123
572
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.5
12.2
528
3866
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
12.1
677
5215
M01AH01
ATC
celecoxib; oral (coxibs)
1.6
11.9
358
2412
N06AB04
ATC
citalopram; systemic
1.5
11.8
422
2958
L04AA17
ATC
[U] adalimumab; parenteral
11.8
11.8
21
18
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
3.5
11.8
54
157
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
11.8
538
3981
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.8
11.7
199
1138
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.0
11.6
160
848
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
11.6
545
4052
D11AH04
ATC
alitretinoin; oral
65.3
11.6
13
*
J01MA12
ATC
levofloxacin; systemic
1.6
11.6
372
2545
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
11.5
1372
11995
N05BA04
ATC
oxazepam; oral
1.5
11.5
474
3428
RJ420
NOMESCO Finland
NA
10.1
11.5
22
22
M09.0*L40.5
ICD-10 Finland
Juvenile arthritis in psoriasis
+∞
11.5
11
*
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
11.4
1017
8471
EBA00
NOMESCO Finland
Extraction of tooth
1.4
11.4
622
4757
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
11.3
1065
8949
J01CE08
ATC
benzathine benzylpenicillin; parenteral
5.1
11.2
34
67
NG1DA
NOMESCO Finland
X-ray of knees
3.3
11.1
55
170
D07AC09
ATC
budesonide; topical
12.8
11.1
19
15
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.8
11.1
186
1058
B01AB05
ATC
enoxaparin; parenteral
1.4
11.1
584
4432
T82
ICPC
Obesity
2.6
11.0
79
311
A07EC02
ATC
mesalazine; oral, rectal
2.1
11.0
119
572
Z71.8
ICD-10 Finland
Other specified counselling
1.5
11.0
429
3065
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
4.2
11.0
41
100
M10.9
ICD-10 Finland
Gout, unspecified
2.0
11.0
141
729
N03AX16
ATC
pregabalin; oral
1.5
11.0
452
3267
K02.1
ICD-10 Finland
Caries of dentine
1.4
10.9
1082
9146
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.1
10.9
125
619
SPAT1211
SPAT
Application of soft bandage
1.8
10.8
178
1007
M79.6
ICD-10 Finland
Pain in limb
1.4
10.8
670
5239
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.0
10.7
145
764
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
10.7
224
1368
M01CB01
ATC
sodium aurothiomalate; parenteral
3.8
10.7
44
118
E66.9
ICD-10 Finland
Obesity, unspecified
2.6
10.6
76
299
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.7
10.6
210
1260
T90
ICPC
Diabetes non-insulin dependent
1.5
10.6
452
3287
J01CF05
ATC
flucloxacillin; systemic
2.5
10.6
82
337
N06AX11
ATC
mirtazapine; oral
1.4
10.5
604
4654
A10BB12
ATC
glimepiride; oral
2.0
10.5
143
756
WQ054
NOMESCO Finland
NA
110.5
10.4
11
*
M073, L409
ICD-10 Finland
NA
+∞
10.4
10
*
WX290
NOMESCO Finland
Other blockade of nerve
1.4
10.4
815
6618
A03
ICPC
Fever
1.6
10.3
278
1816
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
10.3
334
2285
D01AE15
ATC
terbinafine; topical
1.9
10.3
148
801
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.4
10.3
492
3658
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
5.5
10.3
29
53
D07CB01
ATC
triamcinolone and antibiotics; topical
3.3
10.2
50
154
N05BA01
ATC
diazepam; systemic, rectal
1.6
10.2
258
1660
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
10.2
307
2067
C07AB07
ATC
bisoprolol; oral
1.3
10.1
922
7657
R50.9
ICD-10 Finland
Fever, unspecified
1.6
10.1
264
1714
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
10.1
622
4849
WZA90
NOMESCO Finland
Other doctors statement
1.5
10.0
426
3091
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
10.0
233
1466
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.2
10.0
97
445
SPAT1229
SPAT
Assessment of need for aid
1.9
10.0
153
847
WQ066
NOMESCO Finland
NA
40.2
10.0
12
*
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.9
10.0
59
208
SPAT1255
SPAT
Intravenous administration of medicine
2.0
9.9
131
688
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
4.1
9.8
37
92
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.5
9.8
76
313
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
9.7
904
7518
D07XB05
ATC
dexamethasone, combinations; topical
2.7
9.7
65
244
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.9
9.7
147
810
K50.9
ICD-10 Finland
Crohn disease, unspecified
3.8
9.7
40
108
H04.10
ICD-10 Finland
Dry eye syndrome
1.7
9.7
183
1085
J01FA06
ATC
roxithromycin; oral
1.3
9.6
774
6295
C09AA02
ATC
enalapril; systemic
1.5
9.6
373
2658
S21
ICPC
Skin texture symptom/complaint
1.6
9.6
232
1476
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
9.5
745
6026
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
9.5
760
6171
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
9.4
215
1343
R4110
NOMESCO Finland
Physiotherapy
1.4
9.4
513
3905
WQ053
NOMESCO Finland
NA
+∞
9.4
9
*
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
9.4
1367
12127
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.3
9.4
46
143
D11
ICPC
Diarrhoea
1.7
9.4
188
1132
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
9.3
572
4440
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
9.3
162
934
N02AA05
ATC
oxycodone; systemic
1.6
9.3
263
1743
M01AE02
ATC
naproxen; oral, rectal
1.3
9.3
1091
9375
M05BA04
ATC
alendronic acid; oral
1.9
9.2
143
794
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.3
9.2
84
374
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
9.2
313
2167
D64.9
ICD-10 Finland
Anaemia, unspecified
1.7
9.2
188
1142
L60.9
ICD-10 Finland
Nail disorder, unspecified
4.5
9.1
31
70
N07BB01
ATC
disulfiram; oral
2.2
9.1
94
445
A41.9
ICD-10 Finland
Sepsis, unspecified
2.4
9.1
75
318
L60.0
ICD-10 Finland
Ingrowing nail
2.2
9.1
89
412
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
9.1
204
1272
SPAT1301
SPAT
No procedures
1.4
9.1
595
4669
B35.6
ICD-10 Finland
Tinea inguinalis [Tinea cruris]
3.4
9.1
42
125
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.9
9.1
132
718
A28
ICPC
Limited function/disability NOS
1.6
9.1
260
1727
SPAT1312
SPAT
General health counselling
1.4
9.0
580
4533
QXA70
NOMESCO Finland
Guidance related to rash and skin care
36.8
9.0
11
*
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
3.7
9.0
38
105
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
8.9
374
2702
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
3.8
8.9
36
96
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
8.9
300
2069
J01AA02
ATC
doxycycline; systemic
1.3
8.8
1588
14455
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.1
8.8
96
465
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.2
8.8
89
419
C08CA01
ATC
amlodipine; oral
1.3
8.7
669
5381
AA1AD
NOMESCO Finland
CT of head and brain
1.4
8.7
442
3315
D05AD01
ATC
trioxysalen; topical
50.2
8.7
10
*
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.8
8.6
147
841
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
8.6
341
2431
B01AB10
ATC
tinzaparin; parenteral
1.9
8.6
132
729
J01DA06
ATC
[U] cefuroxime; systemic
1.5
8.6
271
1844
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.2
8.6
81
371
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
8.6
692
5607
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.5
8.6
296
2051
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
2.7
8.6
58
221
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.5
8.6
360
2602
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
8.5
226
1472
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
8.4
899
7577
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
8.4
957
8139
162
Kela drug reimbursment
liraglutide
4.0
8.4
32
81
M01AH02
ATC
rofecoxib; oral
1.6
8.4
252
1691
J01FA10
ATC
azithromycin; systemic
1.3
8.4
1092
9460
N03AX12
ATC
gabapentin; oral
1.5
8.4
284
1962
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
4.5
8.4
28
63
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.7
8.3
53
196
4AA12
NOMESCO Finland
NA
9.5
8.3
16
17
C03DA01
ATC
spironolactone; oral
1.6
8.2
200
1273
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
8.2
395
2926
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
8.2
696
5677
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.6
8.1
56
217
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.4
8.1
66
280
SPAT1153
SPAT
Removal of sutures
1.3
8.1
610
4881
F10.09
ICD-10 Finland
Alcohol intoxication UNS
2.9
8.0
47
166
D06BB04
ATC
podophyllotoxin; topical
2.1
8.0
86
416
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.8
8.0
143
835
L30.4
ICD-10 Finland
Erythema intertrigo
3.6
7.9
34
96
M01AC06
ATC
meloxicam; systemic, rectal
1.3
7.9
698
5712
D01AC03
ATC
econazole; topical
1.8
7.9
132
753
N05AH04
ATC
quetiapine; oral
1.5
7.9
283
1978
R5140
NOMESCO Finland
Monitoring the use of the aid
1.6
7.9
201
1296
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
2.6
7.9
55
216
ZX120
NOMESCO Finland
Intravenous
1.6
7.9
179
1122
F10.20
ICD-10 Finland
Alcohol dependence currently independent
2.8
7.8
47
169
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
2.3
7.8
67
293
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
7.8
298
2108
H60.8
ICD-10 Finland
Other otitis externa
2.6
7.8
52
200
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
7.8
786
6558
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.1
7.8
84
406
ZX112
NOMESCO Finland
Subcutaneous
2.8
7.7
49
180
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.2
7.7
75
349
A10BJ06
ATC
semaglutide; parenteral
2.3
7.7
67
296
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
7.7
205
1336
L84
ICD-10 Finland
Corns and callosities
2.3
7.6
69
310
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
7.6
462
3563
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
7.6
469
3630
A10AE05
ATC
insulin detemir; parenteral
1.9
7.6
112
612
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
3.3
7.6
36
111
L08.0
ICD-10 Finland
Pyoderma
4.5
7.6
25
56
R51.80
ICD-10 Finland
Headache
1.5
7.5
243
1657
N06AX16
ATC
venlafaxine; oral
1.5
7.5
240
1635
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.4
7.5
345
2534
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.6
7.5
52
203
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.4
7.5
60
255
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
7.5
501
3932
RS221
NOMESCO Finland
NA
3.2
7.4
37
118
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.8
7.4
122
694
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
7.4
166
1035
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
7.4
227
1536
WX320
NOMESCO Finland
Spinalanesthesy
1.4
7.4
406
3083
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.9
7.4
101
541
M01AH05
ATC
etoricoxib; oral
1.3
7.4
1136
9997
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
3.8
7.3
29
77
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.2
7.3
74
348
R02
ICPC
Shortness of breath/dyspnoea
1.6
7.3
212
1411
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
7.3
238
1627
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
7.3
144
865
-1
NOMESCO Finland
NA
1.3
7.3
577
4635
WQ022
NOMESCO Finland
NA
+∞
7.3
7
*
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
4.9
7.3
22
45
K50.0
ICD-10 Finland
Crohn disease of small intestine
3.2
7.2
36
115
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.4
7.2
388
2931
L30.0
ICD-10 Finland
Nummular dermatitis
2.2
7.2
66
299
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
3.1
7.2
37
121
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
7.2
738
6154
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.2
7.2
71
333
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
1.9
7.2
99
529
S81.9
ICD-10 Finland
Open wound of lower leg, part unspecified
4.4
7.1
24
55
P01AB01
ATC
metronidazole; oral, rectal
1.3
7.1
724
6029
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.6
7.1
179
1153
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.6
7.1
188
1224
WX002
NOMESCO Finland
Sedation and analgesia
1.4
7.1
360
2692
K07
ICPC
Swollen ankles/oedema
2.1
7.0
75
364
L85.9
ICD-10 Finland
Epidermal thickening, unspecified
8.8
7.0
14
16
J01FA01
ATC
erythromycin; systemic
1.5
7.0
239
1652
WX110
SPAT
NA
2.0
7.0
86
442
N06AX21
ATC
duloxetine; oral
1.6
7.0
192
1262
P01BA02
ATC
hydroxychloroquine; oral
1.7
7.0
146
891
M01AX01
ATC
nabumetone; oral
2.0
7.0
85
433
WX780
NOMESCO Finland
Remote monitoring CPAP
2.1
7.0
76
370
N03AG01
ATC
valproic acid; systemic, rectal
1.8
7.0
107
595
L20.0
ICD-10 Finland
Besnier prurigo
1.9
7.0
103
564
N06AB10
ATC
escitalopram; oral
1.4
6.9
335
2483
L03
ICPC
Low back symptom/complaint
1.4
6.9
417
3208
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
6.9
1063
9321
A10BX07
ATC
[U] liraglutide; parenteral
3.4
6.9
31
92
A02BC03
ATC
lansoprazole; oral
1.3
6.9
535
4284
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.1
6.9
74
362
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.9
6.9
95
511
WZC30
NOMESCO Finland
Teaching
1.5
6.8
246
1719
RS340
NOMESCO Finland
NA
8.3
6.8
14
17
K08.3
ICD-10 Finland
Retained dental root
1.7
6.8
131
784
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
2.2
6.8
66
308
205
Kela drug reimbursment
Chronic hypertension
1.3
6.8
518
4134
J45.1
ICD-10 Finland
Nonallergic asthma
1.7
6.8
122
714
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.2
6.8
65
299
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
9.3
6.8
13
14
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
2.4
6.8
55
236
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
6.8
478
3771
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.2
6.7
63
289
A02BC05
ATC
esomeprazole; systemic
1.3
6.7
751
6319
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
6.7
423
3279
R4120
NOMESCO Finland
Occupational therapy
1.8
6.7
116
669
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.6
6.7
150
935
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
2.6
6.7
47
185
WQ020
NOMESCO Finland
NA
22.6
6.7
9
*
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.2
6.6
62
287
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.9
6.5
84
439
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
6.5
808
6884
R53
ICD-10 Finland
Malaise and fatigue
1.4
6.5
343
2581
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
2.0
6.5
73
363
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.8
6.5
101
565
M01AB01
ATC
indometacin; systemic, rectal
1.6
6.5
149
938
J31.0
ICD-10 Finland
Chronic rhinitis
1.7
6.5
131
796
M07
ICD-10 Finland
Psoriatic and enteropathic arthropathies
70.0
6.4
7
*
M40.5
ICD-10 Finland
Lordosis, unspecified
70.0
6.4
7
*
EBA30
NOMESCO Finland
Excision of root of tooth
1.8
6.4
101
569
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
6.4
1186
10595
52100
ICD-8 Finland
Disease of hard tissues of teeth, Dental caries
14.3
6.4
10
7
R05
ICPC
Cough
1.4
6.4
378
2900
F10.25
ICD-10 Finland
Alcohol dependence continuous use
2.6
6.4
42
161
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.5
6.4
231
1617
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.3
6.4
420
3279
E0001A1
ATC
NA
2.9
6.4
37
131
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
3.3
6.3
29
88
M54
ICD-10 Finland
Dorsalgia
1.5
6.3
186
1244
J01AA07
ATC
tetracycline; systemic
1.4
6.3
258
1851
2780A
ICD-9 Finland
Obesity and other hyperalimentation, Obesity
5.2
6.3
18
35
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.9
6.3
84
444
L30.8
ICD-10 Finland
Other specified dermatitis
2.6
6.3
42
163
K50
ICD-10 Finland
Crohn disease [regional enteritis]
9.3
6.3
12
13
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.5
6.3
220
1531
N06AB03
ATC
fluoxetine; oral
1.5
6.3
220
1532
L04AC
ATC
Interleukin inhibitors
+∞
6.3
6
*
M07.2
ICD-10 Finland
Psoriatic spondylitis
+∞
6.3
6
*
L405, L400
ICD-10 Finland
NA
+∞
6.3
6
*
N07.3
ICD-10 Finland
Hereditary nephropathy, not elsewhere classified, diffuse mesangial proliferative glomerulonephritis
+∞
6.3
6
*
M09.0
ICD-10 Finland
Juvenile arthritis in psoriasis
+∞
6.3
6
*
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.6
6.3
161
1044
N06AA09
ATC
amitriptyline; systemic
1.5
6.2
176
1168
S22.3
ICD-10 Finland
Fracture of rib
1.7
6.2
117
697
69282
ICD-8 Finland
Other eczema and dermatitis, E microbis
7.0
6.2
14
20
SGA01
NOMESCO Finland
Tooth opening as first aid
1.4
6.2
271
1970
F10.24
ICD-10 Finland
Alcohol depence active use
3.0
6.2
33
112
Z72.1
ICD-10 Finland
Alcohol use
3.3
6.2
29
90
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.1
6.2
62
296
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.9
6.2
87
471
L21.0
ICD-10 Finland
Seborrhoea capitis
3.3
6.1
28
85
M47.9
ICD-10 Finland
Spondylosis, unspecified
2.1
6.1
61
288
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.0
6.1
73
373
291
Kela drug reimbursment
Tofacitinib
7.7
6.1
13
17
K59.1
ICD-10 Finland
Functional diarrhoea
1.8
6.1
96
538
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
2.8
6.1
36
130
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.8
6.1
94
525
B07.9
ICD-10 Finland
Verruca simplex
2.2
6.1
58
269
H70
ICPC
Otitis externa
2.6
6.1
40
154
RJ412
NOMESCO Finland
NA
8.6
6.1
12
14
N07BA03
ATC
varenicline; oral
1.9
6.0
88
482
N05CF02
ATC
zolpidem; oral
1.4
6.0
303
2259
SPAT1281
SPAT
Other administrative function
1.6
6.0
140
885
N05AA02
ATC
levomepromazine; systemic
1.9
6.0
78
411
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
3.4
6.0
26
76

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3001604) Monocytes [#/volume] in Blood
1723
10120
3.20
162.50
11.4
5.6
e9/l
0.6
0.6
6.77
1566
8750
(3006315) Basophils [#/volume] in Blood
1725
10163
3.19
161.30
11.5
5.6
e9/l
0.0
0.0
5.85
1570
8788
(3019198) Lymphocytes [#/volume] in Blood
1742
10415
3.15
156.77
11.4
5.7
e9/l
1.9
1.9
0.40
1598
9186
(42870588) Differential panel, method unspecified - Blood
1333
6888
2.97
156.75
10.4
5.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1744
10518
3.11
152.82
11.8
5.8
e9/l
0.2
0.2
1.69
1599
9241
(3022096) Basophils/100 leukocytes in Blood
1583
9214
2.91
145.00
11.8
5.9
%
0.7
0.7
3.62
1540
8596
(3006504) Eosinophils/100 leukocytes in Blood
1602
9493
2.87
139.82
11.9
5.8
%
2.9
2.8
0.10
1559
8844
(3019069) Monocytes/100 leukocytes in Blood
1607
9539
2.87
139.77
12.2
6.1
%
8.8
8.7
1.41
1566
8924
(3002030) Lymphocytes/100 leukocytes in Blood
1623
9799
2.83
134.52
12.0
5.9
%
27.4
27.8
0.96
1578
9133
(3013650) Neutrophils [#/volume] in Blood by Automated count
1835
11844
2.99
133.26
14.2
8.9
e9/l
4.2
4.1
1.28
1674
10352
(3018010) Neutrophils/100 leukocytes in Blood
1603
9656
2.80
132.75
11.6
5.7
%
58.1
57.3
2.50
1561
9037
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
261
576
4.94
111.51
1.7
1.6
iu/ml
0.8
11.2
0.46
40
109
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
79
37
22.01
106.48
1.5
1.4
ug/l
9.6
9.2
0.21
79
37
(3037522) Nuclear Ab [Titer] in Serum
629
2676
2.80
98.49
1.4
1.3
titre
375.0
501.4
1.26
123
558
(40768443) Skin Pathology biopsy report
290
812
3.90
90.38
1.3
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1392
9067
2.19
79.48
15.1
9.3
e9/l
0.0
0.0
0.44
1202
7412
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2063
15960
2.58
75.59
11.6
7.5
u/l
80.6
78.3
1.44
1986
15065
(3025159) Blasts/100 leukocytes in Blood
392
1507
2.89
72.48
5.4
4.1
%
0.0
0.3
0.77
108
391
(3017143) Hepatitis C virus Ab [Presence] in Serum
497
2166
2.61
71.96
1.5
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
408
1609
2.83
71.90
5.3
4.1
%
0.1
0.1
2.27
116
465
(3017181) Myelocytes/100 leukocytes in Blood
421
1699
2.77
70.95
5.2
4.0
%
0.5
0.9
2.62
123
506
(3013707) Erythrocyte sedimentation rate by Westergren method
1980
15217
2.38
70.47
6.8
3.9
mm/h
15.0
12.0
13.67
1872
14102
(3002179) Metamyelocytes/100 leukocytes in Blood
394
1541
2.84
70.44
4.9
3.8
%
0.3
0.6
2.36
100
367
(3021879) Hepatitis B virus core Ab [Presence] in Serum
362
1395
2.86
66.32
1.3
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
549
2616
2.40
65.02
1.5
1.6
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
112
187
6.22
64.48
1.4
1.5
iu/ml
57.3
28.5
—
6
11
(3000494) Fungus identified in Specimen by Culture
515
2418
2.42
62.84
1.6
1.4
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
61
49
12.73
62.48
1.9
2.1
mg/l
8.0
8.6
0.28
49
41
(40760892) CBC W Ordered Manual Differential panel - Blood
791
4457
2.13
61.91
7.9
4.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
494
2374
2.34
56.64
2.1
1.7
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
152
387
4.11
53.52
3.8
3.5
e9/l
4.0
4.2
0.77
152
387
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
153
404
3.97
51.23
3.9
3.8
%
55.4
58.3
2.21
153
404
(3021601) Nitrite [Presence] in Urine by Test strip
1379
9872
1.87
50.83
6.4
4.7
estimate
0.0
0.0
0.50
332
1848
(3018095) Leukocytes [#/volume] in Urine
1081
7184
1.88
50.24
4.8
3.6
e6/l
82.8
105.6
0.55
781
5123
(3035350) Ketones [Presence] in Urine by Test strip
1372
9842
1.86
49.87
4.8
3.5
estimate
0.0
0.0
0.00
319
1810
(3037467) Urinalysis macro (dipstick) panel - Urine
1790
13981
1.96
49.87
5.8
4.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1385
9978
1.86
49.52
4.9
3.5
estimate
0.0
0.0
1.08
317
1771
(3026493) Urate [Moles/volume] in Serum or Plasma
876
5468
1.92
49.14
3.0
2.7
umol/l
2142.1
4910.2
1.99
768
4763
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
591
3281
2.05
46.09
1.3
1.2
u/ml
15.4
12.4
0.36
213
1290
(3023368) Bacteria identified in Blood by Culture
876
5596
1.86
44.85
5.4
4.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1246
8868
1.80
44.60
5.9
5.0
g/l
34.6
35.5
7.36
1159
8276
(46235355) HIV 1 and 2 tests - Meaningful Use set
574
3192
2.03
44.35
1.7
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
603
3424
2.00
43.87
1.3
1.3
iu/ml
31.0
35.8
0.36
167
1091
(3026782) Osmolality of Urine
669
3978
1.93
42.32
3.3
2.7
mosm/kgh2o
547.0
555.3
0.44
594
3394
(3002582) Erythrocytes [#/volume] in Urine
936
6190
1.81
42.24
4.0
3.2
e6/l
48.6
87.9
1.68
746
4777
(3021788) Differential panel - Synovial fluid
135
379
3.71
41.36
1.6
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
824
5281
1.83
40.96
9.7
6.5
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
200
723
2.92
40.57
1.2
1.2
u/ml
0.3
1.1
—
7
63
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
317
1446
2.36
40.06
1.7
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
840
5491
1.79
38.64
3.7
3.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1418
10795
1.71
37.36
7.3
6.4
umol/l
11.7
11.6
0.06
1344
10252
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1148
8255
1.71
37.34
2.6
2.2
nmol/l
75.7
77.1
0.84
1048
7427
(3030467) Casts [#/volume] in Urine by Automated count
851
5630
1.77
37.29
3.8
3.1
e6/l
0.3
0.4
1.80
663
4256
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
98
241
4.19
36.09
1.6
1.5
%
54.9
60.5
0.62
60
159
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
976
6792
1.71
35.22
3.9
3.2
u/l
40.2
35.3
0.68
924
6463
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
47
59
8.10
35.01
2.6
3.6
mg/l
7.7
8.4
0.22
27
52
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
377
1961
2.08
34.17
2.7
2.2
g/l
0.2
0.2
1.03
352
1831
(3000850) Epithelial cells [#/volume] in Urine
676
4272
1.79
34.08
3.1
2.6
e6/l
5.3
5.4
0.12
609
3743
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
156
544
2.99
33.68
1.4
1.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
503
2923
1.90
33.10
2.8
2.5
g/l
2.3
2.3
0.14
467
2719
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1332
10181
1.65
32.74
8.2
7.0
mmol/l
1.2
1.2
1.74
1120
8606
(3048689) Calprotectin [Mass/mass] in Stool
422
2335
1.97
32.06
3.1
2.3
ug/g
150.7
134.6
0.54
348
1862
(3018418) pH of Serum or Plasma
873
6016
1.69
31.90
4.4
4.1
ph
7.4
7.4
0.49
182
1159
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
476
2747
1.90
31.88
2.9
2.6
%
21.2
23.3
2.50
417
2356
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
41
51
8.16
30.76
2.4
3.2
au/ml
131.2
64.7
—
8
12
(3022948) Iron [Moles/volume] in Serum or Plasma
526
3174
1.83
30.46
2.8
2.5
umol/l
12.1
13.3
3.02
489
2945
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
76
181
4.30
29.21
1.6
1.4
%
36.5
30.3
0.60
42
116
(3042936) Bacteria identified in Isolate by Culture
494
2966
1.83
28.92
2.5
2.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1219
9301
1.60
28.73
7.5
6.2
mmol/l
1.2
1.2
0.90
1139
8428
(3032080) INR in Blood by Coagulation assay
1120
8381
1.60
28.61
10.8
9.5
inr
1.2
1.3
0.87
352
2389
(3005719) IgG [Mass/volume] in Serum or Plasma
297
1548
2.04
26.42
2.4
2.8
g/l
11.1
10.5
1.56
271
1419
(3013826) Glucose [Moles/volume] in Serum or Plasma
1500
12148
1.58
26.40
6.0
5.0
mmol/l
6.8
6.7
0.75
1436
11398
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
108
355
3.13
25.82
1.1
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
737
5110
1.62
25.01
2.5
2.2
mg/l
3.2
3.0
1.36
645
4344
(3000475) Leukocytes [#/volume] in Synovial fluid
132
495
2.76
24.92
1.8
1.6
e6/l
10983.1
15244.3
0.53
96
358
(3012095) Magnesium [Moles/volume] in Serum or Plasma
533
3423
1.71
24.25
3.8
3.5
mmol/l
0.8
0.8
4.41
508
3219
(3007566) Smooth muscle Ab [Titer] in Serum
137
537
2.64
23.72
1.2
1.2
titre
93.3
93.9
—
9
44
(3008898) HLA-B27 [Presence]
158
665
2.47
23.60
1.1
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
677
4660
1.62
23.40
4.7
3.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
444
2741
1.75
23.18
6.6
6.1
mmol/l
1.0
1.0
0.10
423
2547
(3009871) Measles virus Ab [Titer] in Serum
37
58
6.46
22.65
1.9
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
506
3270
1.68
22.28
3.4
2.9
e6/l
2.9
2.2
0.95
263
1793
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2263
20632
1.91
22.21
23.9
14.1
mg/l
21.9
24.3
3.47
1998
16293
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
143
592
2.50
22.13
1.8
1.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
387
2325
1.78
22.12
2.9
2.7
%
1.8
1.8
0.31
351
2068
(3028026) IgM [Mass/volume] in Serum or Plasma
237
1217
2.05
21.84
1.6
1.8
g/l
1.3
1.4
0.86
223
1118
(3029937) Albumin [Presence] in Urine by Test strip
743
5321
1.56
21.34
5.6
3.9
estimate
0.0
0.0
1.08
314
1768
(3007164) IgA [Mass/volume] in Serum or Plasma
568
3824
1.63
21.18
1.5
1.5
g/l
3.1
2.5
6.96
355
2367
(3031040) Bacteria [#/volume] in Urine by Automated count
1581
13273
1.51
21.15
5.6
4.3
e6/l
241.3
1650.5
2.03
24
200
(3033658) Prothrombin time (PT) actual/Normal
739
5303
1.56
20.97
5.6
3.9
%
86.7
89.8
2.81
721
5169
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
526
3484
1.64
20.91
3.2
2.7
e6/l
1.0
1.1
0.22
286
2005
(3034891) Synovial lining cells/100 cells in Synovial fluid
44
89
5.01
20.66
1.5
1.3
%
6.9
4.3
0.38
12
20
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
991
7599
1.50
20.50
5.3
3.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
192
938
2.13
20.17
1.8
1.9
g/l
1.8
1.6
1.66
156
813
(3009508) Creatinine [Moles/volume] in Urine
878
6604
1.50
19.76
3.6
3.2
mmol/l
7.4
7.7
1.46
752
5578
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
856
6427
1.50
19.34
2.9
2.6
u/l
56.3
57.5
0.20
778
5944
(3041096) Erythrocytes [Presence] in Urine by Automated
731
5316
1.53
19.20
4.5
3.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
132
563
2.42
19.16
1.3
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
871
6589
1.49
18.85
4.4
4.0
mg/mmol
12.4
9.1
1.07
576
4213
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
492
3303
1.61
18.26
2.1
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
295
1727
1.80
18.22
5.2
3.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
782
5834
1.49
17.93
3.7
3.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
372
2337
1.69
17.90
3.5
2.8
umol/l
9.7
8.4
0.32
318
2057
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1082
8605
1.45
17.82
3.4
2.8
ug/l
151.8
133.3
1.31
998
7944
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
370
2371
1.66
16.42
3.4
4.4
u/l
235.1
249.6
1.31
344
2252
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
343
2156
1.68
16.39
3.8
3.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1918
17110
1.50
16.37
29.4
17.1
%
14.0
13.7
16.67
1898
16725
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1042
8325
1.43
16.27
2.3
2.0
pmol/l
92.8
94.7
0.70
617
4395
(3012516) Albumin [Mass/volume] in Urine
818
6258
1.45
16.13
3.4
3.3
mg/l
323.8
316.6
0.02
550
4023
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
356
2275
1.66
15.94
1.9
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
358
2296
1.65
15.80
2.0
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
306
1883
1.71
15.80
4.4
3.9
mmol/l
2.0
2.0
0.05
258
1505
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
595
4297
1.50
15.63
1.4
1.2
u/ml
2.6
1.6
0.74
155
1150
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
380
2481
1.63
15.61
1.9
1.8
%
1.6
1.5
2.31
319
2182
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
477
3286
1.56
15.60
1.6
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
129
597
2.22
15.53
2.8
3.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
285
1741
1.72
15.09
10.9
9.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
85
332
2.61
14.89
1.6
1.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
303
1892
1.68
14.78
4.5
3.9
kpa
5.8
5.9
0.26
295
1833
(3023520) Reticulocytes [#/volume] in Blood
282
1737
1.70
14.46
2.4
2.7
e9/l
69.4
70.3
0.13
206
1327
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
127
608
2.15
14.07
2.1
1.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
297
1871
1.67
13.98
2.4
2.2
nmol/l
334.9
370.6
2.43
271
1725
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
215
1238
1.81
13.95
9.0
8.1
mmol/l
25.1
24.9
0.26
215
1230
(3019309) Folate [Moles/volume] in Red Blood Cells
516
3705
1.49
13.73
1.8
1.7
nmol/l
1124.8
1179.1
0.68
387
2820
(3016650) Hepatitis A virus Ab [Presence] in Serum
80
320
2.55
13.38
1.1
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
964
7794
1.38
13.23
4.1
3.6
ng/l
34.9
50.0
1.01
700
5363
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
749
5810
1.41
13.12
3.1
3.1
ng/l
1571.8
1370.4
0.39
646
4967
(3014111) Lactate [Moles/volume] in Serum or Plasma
287
1821
1.65
13.11
9.4
7.7
mmol/l
1.3
1.4
1.06
273
1752
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
176
973
1.87
13.02
4.4
4.1
mmol/l
24.2
24.1
0.08
159
875
(3022145) Colonoscopy Study observation
348
2321
1.58
12.95
1.5
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
299
1923
1.63
12.94
3.1
2.4
u/l
33.8
64.1
0.66
260
1661
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
18
8
22.65
12.89
2.4
3.3
mg/l
2.4
4.3
—
18
8
(3004588) Protein electrophoresis panel - Serum or Plasma
234
1415
1.72
12.81
1.8
2.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
623
4697
1.43
12.74
1.9
1.5
nmol/l
20.6
20.4
0.11
550
4019
(3024354) Oxygen [Partial pressure] in Venous blood
249
1538
1.69
12.60
3.6
3.2
kpa
4.8
4.6
0.91
241
1486
(3018677) aPTT in Platelet poor plasma by Coagulation assay
446
3181
1.49
12.12
2.2
2.2
s
30.5
29.9
1.47
441
3090
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1563
13762
1.35
11.88
4.2
3.1
u/l
66.9
49.7
6.15
1459
12833
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
92
416
2.26
11.77
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
92
416
2.26
11.77
1.5
1.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
137
721
1.95
11.77
2.2
2.3
ug/l
369.7
521.2
0.58
127
676
(3028707) Methadone [Presence] in Urine by Screen method
67
266
2.56
11.43
4.2
2.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
113
562
2.06
11.38
1.4
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
77
328
2.39
11.31
1.1
1.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
780
6217
1.37
11.26
2.2
2.2
u/l
236.2
238.8
0.02
737
5850
(3023183) Ammonium ion [Moles/volume] in Plasma
97
458
2.16
11.19
3.8
2.8
umol/l
35.6
36.6
0.13
81
390
(3014576) Chloride [Moles/volume] in Serum or Plasma
381
2674
1.50
11.15
9.3
7.3
mmol/l
104.2
104.3
0.22
372
2609
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1730
15551
1.35
11.00
4.2
3.9
pmol/l
14.8
14.8
0.03
1568
14143
(3020630) Protein [Mass/volume] in Serum or Plasma
264
1713
1.60
10.98
1.9
2.8
g/l
66.7
66.6
0.11
245
1565
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
593
4547
1.40
10.76
1.9
1.8
mg/l
1.5
1.2
1.25
455
3487
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2107
19601
1.45
10.63
22.1
13.1
ml/min/173m2
83.5
81.0
5.35
1812
16216
(3044640) Blood type and Crossmatch panel - Blood
807
6525
1.35
10.45
3.0
2.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
152
861
1.81
10.43
2.0
2.0
ug/l
2.2
1.8
0.25
133
766
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
236
1524
1.60
10.00
4.6
4.0
ng/l
94.6
91.2
0.18
202
1341
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
53
201
2.67
9.95
1.2
1.2
u/l
63.3
54.8
0.43
36
140
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
345
2428
1.49
9.90
10.1
8.2
kpa
5.4
5.1
3.78
325
2318
(3027801) Oxygen [Partial pressure] in Arterial blood
345
2429
1.49
9.88
10.1
8.2
kpa
11.8
12.3
0.93
325
2318
(3003396) Base excess in Arterial blood by calculation
345
2430
1.49
9.86
10.1
8.2
mmol/l
1.2
1.1
0.14
294
1899
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2022
18762
1.39
9.58
5.2
4.6
mu/l
1.9
2.1
1.05
1855
17164
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
250
1660
1.56
9.40
3.7
3.9
mmol/l
1.2
1.2
0.39
231
1446
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
98
499
2.00
9.31
1.3
1.2
u/ml
11.8
2.5
—
10
46
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
44
157
2.83
9.28
1.3
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
73
334
2.22
9.16
2.8
3.7
%
1.2
1.3
0.14
68
266
(3014148) Varicella zoster virus Ab [Titer] in Serum
54
216
2.53
9.14
1.1
1.2
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
39
132
2.99
9.04
1.8
1.5
u/ml
20.4
20.8
—
10
31
(3020779) Urea [Moles/volume] in Serum or Plasma
280
1924
1.51
9.00
8.8
7.8
mmol/l
11.3
9.8
2.57
272
1836
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
98
507
1.97
8.91
1.3
1.2
u/ml
13.5
10.0
0.12
16
83
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
71
327
2.21
8.78
1.3
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
201
1290
1.61
8.74
4.2
3.7
ph
7.4
7.4
0.26
34
157
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
177
1102
1.65
8.70
13.0
10.6
mmol/l
24.5
24.3
0.33
158
1043
(3006922) Hepatitis E virus Ab [Presence] in Serum
38
131
2.93
8.55
1.1
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
202
1307
1.59
8.50
4.2
3.7
kpa
5.3
5.1
1.45
189
1214
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
81
400
2.06
8.40
1.2
1.2
u/ml
1.2
5.4
—
5
26
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
193
1239
1.60
8.39
4.2
3.6
mmol/l
2.2
1.8
0.77
150
923
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
186
1186
1.61
8.32
1.6
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
550
4335
1.34
8.12
1.8
1.7
pmol/l
35920598.3
33821925.4
0.02
451
3619
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
101
547
1.88
8.05
1.3
1.2
u/ml
110.9
37.9
—
5
28
(3016502) Oxygen saturation in Arterial blood
306
2188
1.45
8.05
10.6
8.7
%
95.1
95.7
0.92
298
2104
(40768797) Stomach Pathology biopsy report
389
2912
1.40
7.92
1.3
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
87
451
1.96
7.90
3.8
3.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
174
1107
1.61
7.86
1.3
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
56
245
2.31
7.85
1.1
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
123
716
1.75
7.76
2.9
3.4
u/ml
0.3
0.3
0.22
66
399
(3000093) Morphology [Interpretation] in Blood Narrative
46
185
2.51
7.75
1.0
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
80
407
2.00
7.67
1.2
1.2
—
10.9
—
0
5
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2307
22096
1.49
7.58
19.8
10.2
u/l
28.4
26.9
4.06
2270
21356
(3003181) Sodium [Moles/volume] in Urine
71
348
2.07
7.54
1.5
1.3
mmol/l
60.8
61.1
0.02
46
285
(3010144) Erythrocytes [#/volume] in Synovial fluid
47
194
2.45
7.50
1.5
1.3
e6/l
92714.9
111292.7
0.08
34
134
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
110
628
1.79
7.43
2.0
3.7
ratio
1.3
2.5
—
6
55
(3037756) Immunofixation for Serum or Plasma
85
447
1.93
7.43
1.3
1.7
—
—
—
0
0
(3024263) Appearance of Synovial fluid
32
109
2.96
7.39
2.1
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
112
1869
0.58
7.37
1.4
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
35
126
2.80
7.33
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
35
126
2.80
7.33
1.1
1.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
82
429
1.94
7.28
2.7
2.4
%
16.2
16.2
0.04
49
218
(3015377) Calcium [Moles/volume] in Serum or Plasma
821
6921
1.28
7.24
3.7
3.4
mmol/l
2.3
2.4
0.31
727
6087
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
76
392
1.97
7.04
1.3
1.2
u/ml
36.1
45.1
—
8
41
(3034860) Kappa light chains.free [Mass/volume] in Serum
111
646
1.75
7.04
2.0
3.7
mg/l
56.4
67.3
0.38
80
525
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
685
5662
1.29
7.03
1.9
1.7
mmol/l
1.5
1.4
3.43
583
4764
(40760888) Immunoglobulin light chains.free panel - Serum
90
492
1.86
7.01
1.5
3.9
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
125
754
1.69
6.97
2.0
2.5
g/l
11.4
10.4
1.43
108
645
(3019150) Specific gravity of Urine by Refractometry
538
4311
1.31
6.97
5.6
3.9
kg/l
1.0
1.0
0.11
84
620
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
111
648
1.75
6.97
2.0
3.7
mg/l
42.7
80.9
0.98
82
527
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
25
76
3.31
6.96
1.1
1.1
miu/ml
1434.5
1706.5
0.56
25
76
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
132
809
1.67
6.94
2.0
2.5
g/l
4.2
3.8
1.57
96
590
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
132
810
1.66
6.91
2.0
2.5
g/l
7.4
7.3
0.25
98
619
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
132
810
1.66
6.91
2.0
2.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1109
9727
1.25
6.88
4.5
4.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
72
368
1.98
6.85
1.7
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
69
350
2.00
6.72
1.5
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
168
1102
1.56
6.70
3.9
2.8
e6/l
0.3
0.3
0.48
162
1076
(3011288) Drugs identified in Urine by Screen method
76
401
1.92
6.61
4.3
2.6
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
199
1361
1.50
6.56
13.0
10.0
%
93.8
93.9
0.15
199
1355
(3022217) INR in Platelet poor plasma by Coagulation assay
354
2690
1.37
6.53
22.8
24.9
inr
1.2
1.4
1.94
50
381
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
105
616
1.74
6.50
2.2
2.5
g/l
0.0
0.0
1.21
97
571
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
79
425
1.89
6.49
5.9
5.6
iu/ml
359.6
670.7
0.41
12
63
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
78
418
1.89
6.49
1.7
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
67
341
1.99
6.47
1.3
1.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
44
190
2.34
6.41
1.2
1.5
g/l
7.8
7.0
0.57
22
133
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
60
295
2.06
6.38
1.6
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
89
501
1.80
6.35
1.6
1.6
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2297
22084
1.43
6.34
27.5
16.4
umol/l
78.7
78.4
0.14
2297
22075
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
178
1199
1.52
6.31
1.8
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
91
517
1.79
6.30
1.6
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
502
4038
1.30
6.26
4.3
3.7
ng/l
339.1
701.5
0.80
392
3164
(3027315) Oxygen [Partial pressure] in Blood
84
469
1.82
6.16
4.3
4.4
kpa
8.7
8.6
0.26
84
461
(3013290) Carbon dioxide [Partial pressure] in Blood
84
470
1.81
6.12
4.3
4.4
kpa
5.1
5.0
0.30
84
463
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
71
377
1.91
6.09
1.6
1.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
114
697
1.67
6.09
2.1
2.6
g/l
0.7
1.2
0.78
100
615
(3005322) IgE [Units/volume] in Serum or Plasma
184
1259
1.50
6.06
1.4
1.3
u/ml
392.0
209.0
1.08
173
1162
(3002173) Hemoglobin [Mass/volume] in Arterial blood
276
2038
1.40
6.06
11.4
9.0
g/l
121.2
122.1
0.29
269
1962
(3003327) Ova and parasites identified in Stool by Light microscopy
104
622
1.70
6.03
1.8
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
120
1869
0.62
5.98
1.6
1.8
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
43
190
2.28
5.97
1.2
1.5
g/l
3.0
2.9
0.06
20
133
(4062490)
43
190
2.28
5.97
1.2
1.5
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
43
190
2.28
5.97
1.2
1.5
g/l
0.5
0.4
0.68
22
133
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
93
542
1.74
5.92
1.3
1.3
miu/ml
240.7
210.0
0.24
31
249
(40761511) CBC panel - Blood by Automated count
2244
21528
1.37
5.91
20.3
13.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
71
381
1.89
5.91
2.7
2.8
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
98
580
1.72
5.91
2.2
2.5
g/l
0.0
0.0
0.00
90
536
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
197
1374
1.47
5.91
12.7
9.7
%
1.4
1.4
0.06
197
1362
(40768804) Tissue Pathology biopsy report
952
8309
1.23
5.90
2.2
2.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
106
642
1.68
5.88
2.2
2.4
g/l
37.5
37.8
0.23
92
560
(3012501) Base excess in Blood by calculation
83
470
1.79
5.83
4.3
4.4
mmol/l
2.6
2.5
0.10
54
326
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
97
575
1.71
5.82
2.2
2.5
g/l
0.0
0.0
0.00
89
535
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
196
1371
1.47
5.80
13.1
9.9
%
0.6
0.7
1.88
196
1358
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
45
206
2.21
5.76
3.4
4.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
58
293
2.00
5.76
1.4
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
121
763
1.62
5.74
2.1
2.5
g/l
3.0
3.1
0.37
97
605
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
40
175
2.31
5.70
1.4
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
34
139
2.47
5.62
1.5
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
118
744
1.61
5.61
1.7
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
83
476
1.77
5.60
3.7
1.9
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
60
310
1.96
5.60
1.4
1.7
g/l
0.8
0.8
0.00
37
234
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1392
12673
1.22
5.59
3.0
2.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
71
1237
0.56
5.52
1.5
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
47
223
2.13
5.52
1.6
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
78
442
1.79
5.49
1.5
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
86
502
1.74
5.47
1.7
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
70
384
1.85
5.47
1.6
1.3
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
114
720
1.61
5.39
1.7
1.6
titre
673.3
287.6
—
6
29
(3019550) Sodium [Moles/volume] in Serum or Plasma
2224
21360
1.34
5.36
24.2
16.4
mmol/l
139.3
139.7
8.34
2181
20839
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2022
19181
1.27
5.36
6.9
5.7
mmol/mol
41.2
39.9
4.37
1888
17797
(3015235) Bicarbonate [Moles/volume] in Capillary blood
89
528
1.71
5.35
3.3
3.1
mmol/l
26.1
24.8
1.53
83
458
(3023103) Potassium [Moles/volume] in Serum or Plasma
2230
21433
1.34
5.29
24.3
16.5
mmol/l
4.0
4.0
0.60
2186
20877
(3008757) Leukocyte morphology finding [Identifier] in Blood
47
228
2.08
5.23
3.4
4.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
62
333
1.88
5.19
1.3
1.4
—
—
—
0
0
(3010421) pH of Blood
92
557
1.68
5.15
4.1
4.1
ph
7.4
7.4
0.28
83
463
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
25
92
2.73
5.10
1.5
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
40
185
2.18
5.04
1.1
1.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
96
592
1.65
5.02
1.4
1.4
ug/g
274.8
287.3
0.26
62
346
(3044889) 12 lead EKG panel
1586
14707
1.21
4.99
4.0
3.8
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
76
441
1.75
4.97
2.5
2.2
g/l
128.7
129.7
0.14
57
321
(36660697) Celiac disease serology panel - Serum
207
1508
1.41
4.94
1.2
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
36
161
2.25
4.92
1.4
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
165
1159
1.45
4.81
11.9
11.6
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
92
568
1.64
4.80
3.9
3.5
mg/l
1.7
1.5
0.60
87
522
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
596
5040
1.24
4.79
2.8
2.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
138
941
1.49
4.68
4.7
3.8
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
36
165
2.20
4.65
2.0
2.1
%
40.2
45.4
—
5
25
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
54
288
1.89
4.65
1.6
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
46
233
1.99
4.60
2.0
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
193
1409
1.40
4.56
4.1
3.1
e9/l
4.2
4.1
0.27
153
1115
(3048929) Epstein Barr virus Ab [Presence] in Serum
97
616
1.60
4.54
1.2
1.2
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
36
168
2.16
4.47
3.0
1.4
promille
1.8
1.3
1.01
27
133
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
26
105
2.49
4.46
1.2
1.1
u/l
73.8
78.7
0.17
21
82
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
106
691
1.56
4.44
2.9
2.8
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
12
30
4.01
4.43
1.8
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
93
589
1.60
4.41
1.2
1.1
—
—
—
0
0
(3013512) EKG study
696
6026
1.21
4.41
4.2
3.8
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
26
106
2.47
4.38
1.2
1.1
u/l
23.9
23.5
0.02
21
78
(42529406) Shigella sp [Presence] in Stool by Culture
93
594
1.59
4.27
1.2
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
29
126
2.32
4.27
1.6
1.6
u/l
21.1
7.2
0.76
14
66
(3042631) Mycobacterium sp identified in Specimen
53
290
1.85
4.25
3.1
2.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
92
587
1.59
4.24
1.2
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
27
114
2.38
4.23
1.4
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
27
114
2.38
4.23
1.4
1.6
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
18
62
2.92
4.17
2.6
2.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
175
1279
1.40
4.13
1.2
1.3
au/ml
75.6
54.7
—
6
62
(3016038) Potassium [Moles/volume] in Urine
29
128
2.28
4.13
1.2
1.1
mmol/l
27.3
33.9
0.85
23
119
(3016879) Cocaine [Presence] in Urine
89
569
1.58
4.08
3.5
2.0
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
33
157
2.12
3.94
1.2
1.4
mmol/l
1.9
2.0
0.65
26
147
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
83
527
1.59
3.93
2.5
2.3
ug/min
139.7
112.3
0.20
49
324
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
14
43
3.27
3.90
1.2
1.1
—
—
—
0
0
(4035726)
235
1816
1.32
3.90
1.4
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
27
119
2.28
3.87
1.6
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
59
344
1.73
3.87
3.0
3.3
—
—
—
0
0
(3036603) Volume of Urine
31
145
2.15
3.86
2.1
1.4
ml
1407.0
1838.1
—
6
28
(3024891) Influenza virus A+B Ag [Presence] in Specimen
83
530
1.59
3.85
1.2
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
11
29
3.81
3.80
1.2
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
11
29
3.81
3.80
1.2
1.1
%
89.0
95.8
0.30
11
29
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
189
1420
1.36
3.79
2.3
2.4
au/ml
30.8
22.3
—
7
74
(3009466) Valproate [Moles/volume] in Serum or Plasma
56
324
1.74
3.78
5.4
5.6
umol/l
357.0
363.7
0.13
49
288
(3011412) CD3 cells [#/volume] in Blood
37
188
1.98
3.73
2.3
2.2
e9/l
1.1
1.1
0.02
21
105
(3024928) Oxygen saturation in Venous blood
71
440
1.63
3.73
3.0
3.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
40
210
1.92
3.68
3.2
3.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
126
889
1.44
3.66
1.7
1.9
u/l
39.4
39.0
0.08
112
779
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
116
806
1.46
3.65
4.9
4.0
mmol/l
24.9
24.8
0.04
104
754
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
145
1051
1.40
3.63
2.7
2.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
16
56
2.87
3.62
1.1
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
137
2.13
3.55
1.3
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
76
486
1.58
3.53
2.4
2.2
u/l
1816.1
3249.2
0.53
21
198
(3037121) Protein [Mass/volume] in Urine
106
730
1.47
3.50
3.2
3.2
g/l
0.3
0.3
0.07
51
301
(3046861) Legionella sp Ag [Presence] in Urine
6
6
10.02
3.49
1.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
22
93
2.38
3.48
3.2
2.8
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
12
36
3.34
3.47
1.3
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
77
499
1.56
3.39
5.2
4.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
29
140
2.08
3.37
1.7
2.1
%
14.4
13.3
—
10
63
(3000764) Benzodiazepines [Presence] in Urine
91
615
1.50
3.32
3.5
1.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
216
1690
1.30
3.31
4.6
3.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
57
348
1.65
3.21
1.8
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
26
123
2.13
3.20
3.5
3.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
66
419
1.59
3.19
1.3
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
27
130
2.09
3.18
1.9
2.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
91
621
1.48
3.18
3.5
1.9
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
61
381
1.62
3.15
2.9
3.0
nmol/l
0.9
0.8
0.78
44
288
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
83
557
1.51
3.14
1.9
2.0
mg/l
10.6
11.5
0.36
78
512
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
19
79
2.42
3.13
1.7
3.0
umol/l
279.2
138.9
—
9
45
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
61
382
1.61
3.12
1.5
1.5
u/ml
105.9
121.7
0.47
18
63
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
216
1704
1.29
3.12
3.1
2.9
ng/l
269.8
193.9
1.04
189
1547
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
158
1193
1.35
3.12
2.7
3.5
pmol/l
4.4
4.5
0.38
140
1058
(3019060) Gas panel - Arterial blood
184
1421
1.32
3.11
6.4
5.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
44
253
1.75
3.09
1.2
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
66
423
1.58
3.08
1.5
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
20
86
2.34
3.08
1.5
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
90
618
1.47
3.06
3.5
1.9
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
15
56
2.69
3.05
1.7
1.9
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
6
8
7.51
3.05
1.0
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
43
247
1.75
3.04
1.2
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
62
393
1.59
3.03
1.3
1.2
u/ml
241.0
259.9
0.25
46
246
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
39
219
1.79
2.97
1.9
1.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
18
75
2.41
2.97
1.6
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
88
606
1.47
2.96
3.3
1.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
47
280
1.69
2.93
2.7
2.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
24
472
0.50
2.93
1.5
1.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
21
95
2.22
2.89
4.3
3.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
41
236
1.75
2.89
1.9
1.6
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
7
13
5.40
2.87
1.0
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
6
9
6.68
2.87
1.2
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
98
694
1.43
2.86
1.8
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
52
322
1.63
2.82
1.2
1.3
—
—
—
0
0
(3020891) Body temperature
116
852
1.38
2.76
6.2
4.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
22
104
2.13
2.74
4.0
3.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
49
774
0.63
2.74
1.8
1.6
mg/l
2.8
4.0
0.72
39
552
(4010399)
187
1475
1.29
2.74
1.6
1.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
172
1342
1.30
2.73
9.5
7.8
mmol/l
25.3
24.5
2.07
162
1249
(4198724)
17
72
2.37
2.72
1.8
1.3
—
—
—
0
0
(3036489) Thrombin time
108
789
1.39
2.66
2.5
2.2
s
22.5
21.5
0.51
95
693
(4133840)
13
49
2.66
2.62
1.3
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
15
61
2.47
2.62
1.9
2.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
14
55
2.55
2.61
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
28
148
1.90
2.60
1.3
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
27
141
1.92
2.60
1.1
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
435
3776
1.18
2.58
3.3
3.0
mmol/l
2.5
2.4
3.22
388
3341
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
5
7
7.15
2.55
1.0
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
260
2152
1.23
2.54
4.4
4.2
ug/l
4.7
24.5
3.13
219
1752
(3004716) Salmonella sp identified in Stool by Organism specific culture
129
979
1.33
2.51
1.3
1.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
42
255
1.66
2.49
2.1
2.3
mg/l
36.9
24.5
0.52
16
68
(3050129) First trimester maternal screen panel - Serum or Plasma
18
366
0.49
2.47
2.1
1.5
—
—
—
0
0
(3001729) Color of Synovial fluid
7
16
4.38
2.47
2.4
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
28
151
1.86
2.47
1.3
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
114
852
1.35
2.46
5.7
6.3
%
1.7
1.7
0.01
106
793
(3026692) Albumin [Mass/volume] in Peritoneal fluid
15
63
2.39
2.46
3.1
1.5
g/l
12.6
13.3
—
10
48
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
32
181
1.78
2.43
1.2
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
39
235
1.67
2.39
1.1
1.1
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
5
8
6.26
2.37
1.6
2.3
mmol/l
11.6
22.6
—
5
8
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
12
46
2.62
2.36
1.2
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2078
20173
1.17
2.35
5.1
4.5
mmol/l
6.2
6.0
6.21
1891
18420
(3045414) Leukocytes [Presence] in Urine
121
922
1.33
2.32
1.7
1.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
15
65
2.32
2.31
1.3
1.6
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
76
537
1.43
2.30
1.3
1.3
mg/l
502.1
523.0
0.21
68
502
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
22
112
1.97
2.30
2.6
2.3
%
94.7
95.7
0.04
22
107
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
27
148
1.83
2.28
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
27
148
1.83
2.28
1.3
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
13
53
2.46
2.27
1.1
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
16
72
2.23
2.27
1.9
1.7
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
12
47
2.56
2.27
1.2
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
12
47
2.56
2.27
1.2
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
12
47
2.56
2.27
1.2
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
12
47
2.56
2.27
1.2
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
218
1795
1.23
2.26
2.3
2.4
ug/l
5.8
7.6
1.50
191
1616
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
555
6183
0.87
2.26
4.2
4.2
%
22.4
21.6
0.48
248
3026
(3019832) Treponema pallidum Ab [Presence] in Serum
177
1427
1.26
2.22
1.6
1.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
16
73
2.20
2.21
1.1
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
33
195
1.70
2.19
1.7
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
33
195
1.70
2.19
1.7
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
33
195
1.70
2.19
1.7
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
316
2708
1.19
2.18
1.4
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
11
42
2.63
2.18
1.4
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
217
1794
1.23
2.18
2.0
2.0
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
65
452
1.45
2.16
2.7
3.5
u/ml
189.0
916.2
0.69
59
419
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
27
151
1.80
2.16
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
27
151
1.80
2.16
1.3
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
198
1623
1.24
2.15
1.9
1.9
—
—
—
0
0
(3035611) Eosinophils/100 leukocytes in Synovial fluid
6
14
4.29
2.15
2.7
1.1
%
0.5
0.5
—
6
8
(21494567) Legionella sp IgM Ab [Presence] in Serum
7
19
3.69
2.15
1.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
7
19
3.69
2.15
1.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
28
159
1.77
2.13
2.1
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
63
437
1.45
2.13
1.2
1.5
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
17
81
2.11
2.12
3.6
2.7
e6/l
410.0
785.3
0.91
12
66
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
24
130
1.85
2.12
1.2
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
15
68
2.21
2.11
1.1
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
38
236
1.62
2.11
3.0
2.8
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
25
138
1.82
2.09
2.8
2.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
13
56
2.33
2.04
1.2
1.1
pmol/l
188.1
276.1
—
8
41
(3007930) Methemoglobin/Hemoglobin.total in Blood
110
846
1.31
2.01
5.8
6.4
%
0.8
0.9
1.47
103
790
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
20
104
1.93
2.00
2.4
2.3
u/ml
943.9
1120.9
0.21
20
104
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
398
4503
0.86
2.00
2.9
3.0
ug/l
0.7
0.8
1.51
269
2983
(3017354) Segmented neutrophils/100 leukocytes in Blood
33
201
1.65
1.98
2.9
3.8
%
59.2
56.2
0.32
27
135
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
33
201
1.65
1.98
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
33
201
1.65
1.98
1.4
1.7
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
89
665
1.35
1.98
6.4
7.6
mmol/l
1.3
1.3
0.03
78
576
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
7
21
3.34
1.96
1.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
18
91
1.99
1.95
1.9
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
18
91
1.99
1.95
1.9
1.9
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
8
27
2.97
1.93
1.1
1.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2039
19838
1.14
1.93
4.8
4.0
mmol/l
1.4
1.3
11.06
1889
18196
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
32
195
1.65
1.93
1.8
1.5
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
25
142
1.77
1.93
2.1
2.0
mmol/l
7.1
6.9
0.13
18
91
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
15
71
2.12
1.92
3.7
2.4
e6/l
1201.7
25518.9
—
7
45
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
10
39
2.57
1.92
1.1
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
109
844
1.30
1.91
2.7
2.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
18
92
1.96
1.90
1.9
1.9
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
36
228
1.59
1.87
1.3
2.2
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
16
79
2.03
1.85
2.9
2.6
umol/l
26.8
30.1
—
9
55
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
18
93
1.94
1.85
1.2
1.1
—
—
—
0
0
(1002224) Polysomnography panel
111
868
1.29
1.83
1.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
39
254
1.54
1.81
1.4
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
61
438
1.40
1.76
1.5
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
16
81
1.98
1.74
1.1
1.0
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
32
201
1.60
1.74
2.4
3.0
mg/l
25.4
29.4
0.12
22
152
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
8
30
2.67
1.72
1.3
1.3
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
13
3.85
1.71
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
53
374
1.43
1.69
1.6
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
31
195
1.60
1.68
1.2
1.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
19
3.16
1.66
1.0
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
18
97
1.86
1.66
1.3
1.2
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
18
97
1.86
1.66
1.2
1.1
u/ml
—
14.6
—
0
9
(3050794) Legionella sp Ab [Presence] in Serum
7
25
2.80
1.65
1.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
20
112
1.79
1.64
2.1
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
20
112
1.79
1.64
2.1
1.7
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
32
2.50
1.59
2.0
1.7
ng/l
123.2
131.1
—
8
32
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
8
32
2.50
1.59
1.1
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
26
2.70
1.58
1.0
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
7
26
2.70
1.58
1.1
1.7
umol/l
63.1
47.5
—
7
26
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2110
20642
1.13
1.57
5.4
4.4
mmol/l
4.5
4.7
6.62
1974
19166
(3016750) Collection duration of Urine
22
129
1.71
1.56
2.0
2.1
min
495.6
490.6
0.06
15
93
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
20
114
1.76
1.56
1.8
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
20
114
1.76
1.56
1.8
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
20
114
1.76
1.56
1.8
1.8
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
68
509
1.35
1.56
1.5
1.3
u/l
13.0
9.9
0.77
53
406
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
111
889
1.26
1.55
2.3
1.8
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
27
168
1.61
1.55
2.1
2.3
ml
850.3
624.4
0.84
16
113
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
12
57
2.11
1.55
1.0
1.1
%
90.0
92.8
—
7
31
(3000492) Spirometry study
235
2030
1.17
1.53
1.4
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
48
340
1.42
1.53
1.3
1.1
iu/ml
6.3
113.6
2.05
12
72
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
20
115
1.75
1.52
1.5
1.4
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
27
2.60
1.51
2.9
2.3
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
33
217
1.53
1.51
1.6
1.3
mosm/kgh2o
270.6
280.5
0.75
22
170
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
24
146
1.65
1.50
1.2
1.2
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
14
72
1.95
1.48
1.6
2.4
—
32039.4
—
0
15
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
117
1.72
1.45
1.2
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
22
2.73
1.43
1.3
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
6
22
2.73
1.43
1.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
13
66
1.97
1.43
1.2
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
106
854
1.25
1.43
2.3
1.9
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
96
767
1.26
1.39
3.9
3.5
u/ml
91.9
5309.4
0.83
87
657
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
22
134
1.65
1.39
2.2
2.0
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
22
134
1.65
1.39
2.5
2.3
e9/l
0.2
0.2
0.12
17
120
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
63
476
1.33
1.39
1.3
1.3
mmol/l
3.9
3.8
0.11
56
444
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
37
255
1.46
1.38
1.5
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
123
1013
1.23
1.37
4.8
3.3
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
5
17
2.94
1.36
1.2
1.3
mmol/l
136.4
145.5
—
5
12
(3032057) Clostridioides difficile [Presence] in Stool
10
47
2.13
1.33
1.8
2.0
—
—
—
0
0
(44790048)
36
249
1.45
1.33
1.7
1.5
—
—
—
0
0
(44806118)
36
249
1.45
1.33
1.7
1.5
—
—
—
0
0
(44790047)
36
249
1.45
1.33
1.7
1.5
—
—
—
0
0
(44790049)
36
249
1.45
1.33
1.7
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1932
18860
1.10
1.32
26.1
15.1
%
39.3
40.0
2.28
1311
13581
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
24
152
1.58
1.31
1.1
1.2
mg/l
46.0
43.0
0.06
16
124
(3045683) HLA typing for celiac disease panel - Blood or Tissue
19
113
1.69
1.31
1.0
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
37
258
1.44
1.31
1.5
1.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2331
23008
1.16
1.30
35.6
20.7
e9/l
255.0
249.3
3.74
2297
22436
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
37
259
1.43
1.29
1.5
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
19
114
1.67
1.28
1.8
1.8
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
19
115
1.66
1.24
1.5
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
123
1.63
1.24
1.2
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
250
2211
1.15
1.23
1.7
1.6
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
22
139
1.59
1.23
2.7
2.3
e6/l
268.1
548.1
2.82
17
121
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
287
2564
1.13
1.22
9.4
6.9
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
11
56
1.97
1.22
1.0
1.4
%
92.8
91.8
—
6
31
(3024731) MCV [Entitic volume]
2331
23021
1.16
1.22
35.5
20.6
fl
91.9
91.0
15.74
2309
22696
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
19
2.63
1.21
1.6
2.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
8
37
2.17
1.21
1.3
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
8
37
2.17
1.21
1.4
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
16
93
1.73
1.21
1.6
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
16
93
1.73
1.21
1.6
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
14
78
1.80
1.21
6.1
2.9
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
14
78
1.80
1.21
1.4
1.8
mmol/l
8.0
7.4
—
9
49
(3035941) MCH [Entitic mass]
2331
23023
1.16
1.20
35.4
20.6
pg
30.5
30.3
3.70
2308
22695
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
23
148
1.56
1.20
1.0
1.1
mg/l
313.8
293.2
0.08
16
125
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
17
101
1.69
1.19
1.0
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
2331
23025
1.16
1.19
35.6
20.6
e12/l
4.4
4.5
9.65
2293
22388
(3052592) Norovirus Ag [Presence] in Stool
8
38
2.11
1.18
1.3
1.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
21
133
1.58
1.17
3.4
1.9
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
23
149
1.55
1.17
1.3
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
127
0.47
1.16
6.8
6.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
159
1366
1.17
1.16
1.2
1.3
—
—
—
0
0
(4094501)
46
611
0.75
1.16
1.1
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
2331
23031
1.15
1.16
35.7
20.7
e9/l
7.1
6.7
12.41
2294
22393
(3000963) Hemoglobin [Mass/volume] in Blood
2331
23032
1.15
1.15
35.8
20.8
g/l
134.2
136.1
7.27
2311
22707
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
60
465
1.30
1.15
1.3
1.5
e6/l
9.8
28.8
0.76
39
355
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
60
465
1.30
1.15
1.3
1.5
e6/l
172.8
861.6
1.32
42
372
(4211845)
15
87
1.73
1.15
5.9
2.8
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
46
344
1.34
1.13
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
151
1296
1.18
1.12
1.1
1.2
iu/ml
51.2
148.6
7.72
56
480
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
66
520
1.28
1.12
1.1
1.1
u/ml
3.0
3.9
—
6
63
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
30
2.34
1.12
1.3
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
32
225
1.43
1.12
1.2
1.5
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
5
21
2.38
1.09
1.2
1.1
ug/l
127.2
230.7
—
5
10
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
21
2.38
1.09
1.2
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
82
666
1.24
1.09
6.4
4.2
mmol/l
3.9
3.9
0.07
76
618
(40757373) Influenza virus identified in Isolate
8
41
1.95
1.08
1.3
1.9
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
8
41
1.95
1.08
1.3
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
59
1.87
1.07
1.2
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
94
777
1.22
1.06
1.5
1.4
iu/l
28.5
30.5
0.26
76
660
(3025468) Yersinia sp identified in Specimen by Organism specific culture
35
253
1.39
1.06
1.6
1.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
10
52
1.93
1.06
2.4
1.6
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
14
82
1.71
1.05
1.3
8.8
mg/l
78.5
76.5
—
6
64
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
67
1.79
1.04
1.2
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
35
254
1.38
1.04
1.6
1.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
23
154
1.50
1.03
2.9
2.2
e6/l
568.7
683.4
0.35
11
69
(44786800) Granulocytes/100 leukocytes in Body fluid
5
22
2.28
1.03
1.2
1.5
%
31.8
21.1
—
5
14
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
5
22
2.28
1.03
1.0
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
191
1683
1.15
1.03
2.8
2.6
ml/min/173m2
58.1
67.1
2.31
78
650
(3005988) Vibrio sp identified in Specimen by Organism specific culture
35
255
1.38
1.02
1.6
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
83
1004
0.82
1.00
1.6
1.7
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
9
48
1.88
1.00
1.0
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
35
2.00
1.00
1.0
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
47
605
0.77
0.98
1.5
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
14
84
1.67
0.97
3.3
2.6
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
23
157
1.47
0.96
1.3
1.3
u/ml
0.8
0.8
—
7
78
(44806071)
6
27
2.23
0.93
1.2
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
67
545
1.24
0.91
1.3
1.2
—
—
—
0
0
(4027681)
18
118
1.53
0.90
1.4
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
63
1.75
0.90
1.2
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
32
236
1.36
0.89
1.5
1.3
nmol/l
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
92
775
1.19
0.89
2.0
1.8
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
29
2.07
0.89
1.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
12
71
1.69
0.88
1.1
1.0
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
34
254
1.34
0.88
1.6
1.5
nmol/l
0.2
0.3
1.15
22
191
(3006270) Folate [Moles/volume] in Blood
24
169
1.42
0.87
1.2
1.2
nmol/l
304.8
383.8
1.33
17
150
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
61
495
1.24
0.86
1.5
2.0
iu/l
2.4
5.1
3.85
13
173
(40768446) Kidney Pathology biopsy report
13
80
1.63
0.84
1.4
1.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
24
332
0.72
0.84
1.7
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
28
205
1.37
0.83
1.2
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
34
257
1.33
0.83
1.4
1.3
mmol/l
8.3
7.4
0.73
26
192
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2081
20506
1.08
0.83
5.0
4.4
mmol/l
1.4
1.4
12.93
1922
18927
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
36
275
1.31
0.82
1.5
1.3
nmol/l
0.6
0.6
0.03
36
262
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
33
249
1.33
0.82
1.5
1.4
pmol/l
215.8
297.2
1.36
26
196
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
12
73
1.65
0.81
2.1
2.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
14
89
1.58
0.81
1.1
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2130
21014
1.09
0.81
5.6
4.9
mmol/l
2.7
2.8
4.68
1973
19403
(3048879) Bone marrow aspiration report
10
58
1.73
0.79
1.5
1.8
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
11
66
1.67
0.78
2.1
1.9
ug/l
0.4
1.3
2.06
11
59
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
27
0.00
0.77
0.0
1.1
—
0.5
—
0
20
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
100
0.50
0.77
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
59
1.70
0.75
1.2
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
11
67
1.64
0.75
1.2
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
20
141
1.42
0.74
1.2
1.2
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
9
54
1.67
0.74
1.1
1.4
mmol/l
-1.0
0.8
—
9
48
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
64
533
1.21
0.73
1.3
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
23
311
0.74
0.72
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
23
311
0.74
0.72
1.6
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
23
311
0.74
0.72
1.6
1.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
25
2.00
0.72
1.0
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
10
60
1.67
0.72
1.4
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
25
185
1.35
0.72
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
23
310
0.74
0.71
1.6
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
54
446
1.22
0.68
1.3
2.0
nmol/l
0.9
0.8
0.48
45
368
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
12
77
1.56
0.68
1.7
1.8
ug/l
16.6
19.2
0.16
12
68
(3028717) Thiamine [Mass/volume] in Blood
5
27
1.85
0.68
1.2
1.3
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
27
1.85
0.68
1.4
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
11
69
1.60
0.68
4.1
5.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
55
458
1.21
0.65
1.8
1.9
pmol/l
193.0
209.5
0.56
50
434
(3013005) Retinol [Moles/volume] in Serum or Plasma
12
78
1.54
0.65
1.6
1.5
umol/l
1.7
2.0
0.48
12
71
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
12
78
1.54
0.65
1.2
1.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
11
70
1.57
0.65
3.6
2.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
62
1.62
0.65
1.3
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
16
112
1.43
0.63
2.1
3.1
ph
7.4
7.4
—
6
35
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
13
188
0.69
0.62
2.0
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
8
49
1.63
0.62
4.1
1.7
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
29
226
1.29
0.61
1.0
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
17
122
1.40
0.60
1.1
1.2
nmol/l
142.7
139.1
0.15
17
122
(3019420) Tryptase [Mass/volume] in Serum or Plasma
15
105
1.43
0.60
1.4
1.6
ug/l
9.6
8.6
0.16
15
91
(3029075) Extractable nuclear Ab panel - Serum
8
53
1.51
0.58
1.1
1.0
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
17
123
1.38
0.57
1.3
1.2
ratio
1.0
1.1
—
10
48
(3000012) Reticulocyte production index
15
106
1.42
0.57
1.9
1.6
—
—
—
0
0
(3019225) pH of Specimen
223
2065
1.09
0.57
4.3
4.3
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
36
1.67
0.56
2.0
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
19
141
1.35
0.56
1.1
1.4
mmol/l
11.5
12.3
—
8
40
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
65
1.54
0.55
1.3
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
719
7454
0.95
0.55
3.3
2.8
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
71
617
1.16
0.54
1.7
1.6
mu/l
279.5
312.9
0.36
64
563
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
38
1.58
0.54
1.0
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
9
60
1.50
0.54
1.2
1.8
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
60
1.50
0.54
1.2
1.1
—
—
—
0
0
(4281824)
26
204
1.28
0.54
1.3
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
36
296
1.22
0.51
1.1
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
41
1.46
0.50
2.2
2.2
umol/l
14.5
19.4
—
6
41
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
67
1.49
0.49
2.4
2.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
67
1.49
0.49
2.4
2.9
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
12
84
1.43
0.49
10.1
12.9
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
15
110
1.37
0.48
1.3
1.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
39
326
1.20
0.48
1.5
1.2
u/ml
2.7
3.3
0.23
12
109
(3003338) MCHC [Mass/volume]
1729
17533
0.96
0.48
31.8
18.1
g/l
331.4
332.6
5.85
1720
17412
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
7
46
1.52
0.48
1.1
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
14
102
1.37
0.47
1.9
2.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
59
675
0.87
0.46
2.1
1.8
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
13
94
1.38
0.46
2.8
2.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
21
165
1.28
0.45
1.9
1.5
g/l
1.0
1.0
0.04
21
165
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
31
256
1.21
0.44
1.5
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
51
1.37
0.44
3.1
2.8
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
22
175
1.26
0.43
2.9
2.1
u/field
5.7
1.8
—
7
78
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
60
527
1.14
0.43
1.1
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
11
78
1.41
0.43
1.3
1.9
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
5
32
1.56
0.42
1.0
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
18
140
1.29
0.42
1.3
1.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
0.1
—
0
9
(3001556) Androgen free Index in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
0.1
—
0
9
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
0.1
—
0
10
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
34
1.47
0.40
1.6
1.2
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
27
223
1.21
0.39
2.5
2.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
26
214
1.22
0.39
1.3
1.2
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
5
35
1.43
0.39
1.2
1.1
—
6.0
—
0
6
(3025130) Human papilloma virus identified in Specimen
25
205
1.22
0.39
2.1
1.9
—
—
—
0
0
(3024932) HLA-DR beta [Type]
10
71
1.41
0.39
1.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
71
1.41
0.39
1.3
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
20
248
0.80
0.39
1.5
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
21
258
0.81
0.38
1.1
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
20
247
0.81
0.38
1.5
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
268
2817
0.95
0.37
1.4
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
21
257
0.82
0.37
1.6
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
15
116
1.29
0.37
1.2
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
15
116
1.29
0.37
2.0
2.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
19
152
1.25
0.37
1.1
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
18
143
1.26
0.37
1.3
1.3
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
9
70
1.29
0.36
1.3
1.2
%
116.2
108.6
—
9
61
(3032773) Endomysium IgG Ab [Titer] in Serum
20
162
1.24
0.35
1.2
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
36
310
1.16
0.35
1.2
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
15
117
1.28
0.35
1.1
1.1
u/l
0.9
1.1
—
5
64
(1617658) Protocol used for examination of sentinel lymph nodes
13
167
0.78
0.34
1.1
1.1
—
—
—
0
0
(4306422)
36
311
1.16
0.34
1.3
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
32
274
1.17
0.34
1.1
1.0
u/ml
1.2
2.2
1.94
12
123
(3039000) Anion gap in Blood
54
482
1.12
0.33
8.8
8.9
mmol/l
11.2
11.3
0.06
48
427
(3018572) Chloride [Moles/volume] in Blood
54
483
1.12
0.32
8.8
8.9
mmol/l
104.0
105.5
2.16
48
428
(3044927) Protein electrophoresis panel - Urine
27
229
1.18
0.32
1.3
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
26
220
1.18
0.31
1.3
1.5
e6/l
17664.3
75327.6
1.13
16
133
(3045142) Bone marrow Pathology biopsy report
29
248
1.17
0.31
1.3
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
39
342
1.14
0.31
1.3
1.1
u/ml
4.8
2.0
0.28
16
145
(3017446) Testosterone [Moles/volume] in Serum or Plasma
177
1676
1.06
0.30
2.1
2.2
nmol/l
11.3
13.0
2.04
152
1473
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
75
1.33
0.30
2.8
2.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
17
207
0.82
0.30
1.3
1.0
u/ml
0.1
0.4
—
6
54
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
13
103
1.26
0.28
1.3
1.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
64
1.25
0.27
1.3
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
25
215
1.16
0.26
1.2
1.1
u/ml
0.7
3.8
—
10
81
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
16
132
1.21
0.25
9.8
13.9
nmol/l
1115.8
837.3
1.82
16
127
(3024471) HLA-A [Type]
9
73
1.23
0.25
1.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
39
435
0.89
0.25
1.3
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
43
476
0.90
0.24
1.8
2.0
—
—
—
0
0
(44813793)
15
124
1.21
0.24
1.1
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
103
970
1.06
0.23
1.1
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
33
294
1.12
0.23
1.2
1.2
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
16
134
1.20
0.23
1.8
2.1
ug/l
2.7
2.1
0.41
11
115
(3023410) Appearance of Cerebral spinal fluid
25
219
1.14
0.22
1.3
1.7
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
13
107
1.22
0.21
1.3
1.8
—
10.4
—
0
7
(3024869) Neuronal Ab [Presence] in Serum
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
42
1.19
0.21
1.6
1.6
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
4176.2
—
0
6
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
2.4
—
0
10
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
2.6
—
0
6
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.6
—
13.1
—
0
12
(3015183) Erythrocyte sedimentation rate
8
104
0.77
0.21
1.1
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
49
450
1.09
0.21
4.3
3.7
mg/l
28.4
26.9
0.10
29
282
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
5.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
52
563
0.92
0.20
1.7
1.5
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.4
—
357.8
—
0
14
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
48
1.25
0.20
1.2
1.1
—
—
—
0
0
(4268621)
25
221
1.13
0.20
2.7
2.3
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
28
250
1.12
0.19
1.5
1.5
e6/l
2599.9
1764.8
0.21
22
181
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
23
203
1.13
0.19
1.3
1.6
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
15
175
0.86
0.18
1.1
1.4
pmol/l
72.4
222.7
—
8
59
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
35
318
1.10
0.18
1.5
1.2
u/ml
8.8
5.2
0.41
16
142
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
248
2556
0.97
0.18
4.6
4.5
%
31.0
32.3
1.01
171
1723
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
180
1737
1.04
0.18
1.4
1.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
66
0.76
0.17
1.2
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
125
1303
0.96
0.17
4.4
2.8
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
79
0.76
0.15
1.2
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
78
1.15
0.15
1.2
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
26
237
1.10
0.14
1.2
1.1
u/ml
2.1
2.9
—
9
86
(3005570) Glucose [Moles/volume] in Urine
22
199
1.11
0.13
1.7
2.0
—
—
—
0
0
(3017704) Immunofixation for Urine
15
132
1.14
0.13
1.1
1.6
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
14
159
0.88
0.13
1.4
1.5
—
73.3
—
0
16
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
10
117
0.85
0.13
1.1
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
33
307
1.08
0.12
1.2
1.1
u/ml
3.1
6.1
0.59
16
154
(4034850)
65
680
0.95
0.11
15.5
9.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
33
308
1.07
0.11
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
35
329
1.06
0.10
2.0
1.6
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
12
107
1.12
0.08
1.2
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
561
5662
0.99
0.08
1.5
1.4
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
10
88
1.14
0.08
2.0
1.6
—
1679021.4
—
0
7
(3043410) Blood group antigens tested for on Red Blood Cells
7
66
1.06
0.08
1.9
1.9
—
—
—
0
0
(44806420)
7
67
1.04
0.08
3.7
2.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
72
0.83
0.07
1.2
1.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
8
93
0.86
0.06
1.9
1.4
umol/l
24.5
28.3
—
8
88
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
95
0.84
0.06
1.4
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
13
142
0.92
0.06
1.1
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
101
0.89
0.06
1.2
1.3
—
—
—
0
0
(4024509)
20
189
1.06
0.04
1.7
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
46
474
0.97
0.04
1.1
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
22
209
1.05
0.04
1.2
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
32
308
1.04
0.04
1.1
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
31
299
1.04
0.03
1.2
1.1
u/ml
0.6
1.9
0.95
15
128
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
24
230
1.04
0.03
2.2
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
29
280
1.04
0.03
1.3
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
11
117
0.94
0.01
1.4
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
769
7677
1.00
0.01
4.4
4.9
ug/l
2.4
2.8
0.40
675
6890
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
27
264
1.02
0.00
1.8
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
10
101
0.99
0.00
1.0
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
28
285
0.98
0.00
1.2
1.1
u/ml
0.3
2.2
—
7
67
(3045788) Cell count panel - Pleural fluid
20
201
0.99
0.00
1.4
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
20
201
0.99
0.00
2.3
2.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
60
604
0.99
0.00
1.5
1.5
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
16
158
1.01
0.00
1.3
1.6
ug/l
2.0
4.8
0.92
11
134
(40768806) Pleura Pathology biopsy report
21
208
1.01
0.00
1.6
1.6
—
—
—
0
0
(4146454)
22
222
0.99
0.00
3.2
2.8
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
59
1.02
0.00
1.8
1.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
7
72
0.97
0.00
1.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
7
71
0.99
0.00
1.6
1.4
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
9
93
0.97
0.00
1.1
1.1
%
104.9
95.1
—
9
74
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
42.9
—
0
5
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022725) Serotonin [Moles/volume] in Serum
0
6
0.00
0.00
0.0
2.0
—
1140.2
—
0
6
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
6
64
0.94
0.00
3.2
2.6
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
7
74
0.95
0.00
1.1
1.1
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
259.0
—
0
5
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
4.2
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.4
—
2.2
—
0
9
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint L12_PSORI_NAS and mortality.

Females

Parameter HR [95% CI] p-value
L12_PSORI_NAS 1.614 [1.41, 1.85] < 0.001
Birth year 0.995 [0.99, 1.0] 0.201

During the follow-up period (1.1.1998 — 31.12.2019), 797 out of 4508 females with L12_PSORI_NAS died.

Males

Parameter HR [95% CI] p-value
L12_PSORI_NAS 2.294 [2.01, 2.61] < 0.001
Birth year 0.984 [0.97, 0.99] 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 1294 out of 5256 males with L12_PSORI_NAS died.

Mortality risk

Mortality risk for people of age

years, who have L12_PSORI_NAS.

N-year risk Females Males
1 0.15% 0.417%
5 0.863% 2.543%
10 2.182% 6.287%
15 4.563% 11.503%
20 8.04% 18.71%

Relationships between endpoints

Index endpoint: L12_PSORI_NAS – Other and unspecified psoriasis

GWS hits: 9

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data